BENCHMARKS REPORT
Industry Measure: Company Level Data
| SIC: | 2835 |
| INDUSTRY: | IN VITRO,IN VITRO DIAGNOSTICS |
| BENCHMARKS FOR THE INDUSTRY |
| NO. OF SEGMENTS REPORTING IN THE INDUSTRY: 76 |
|
1997 SALES FOR THE INDUSTRY: $ 4544 (Total Sales in $Millions) |
|
OPERATING MARGIN: 1.7 (EBIT (divided by) Sales) |
|
CAPITAL INTENSITY: 137.9 (Sum of Total Debt plus Shareholder Equity (divided by) Sales) |
|
SALES GROWTH: 22.7 (Compound 3-Year Growth Rate in Sales for the Median Participant in the Industry) |
| BENCHMARKS FOR THE TOP FOUR COMPETITORS |
| ROE: Net Profits (divided by) Total Shareholder Equity RONCE: EBIT (divided by) Sum of Total Debt plus Shareholders' Equity |
| Competitor/Rank by Sales |
Market Share (% Ind. Sales) |
ROE | RONCE |
| #1: MALLINCKRODT INC |
41.0 | 14.9 | 18.6 |
| #2: CHIRON CORP |
23.2 | 5.8 | 7.7 |
| #3: IDEXX LABS INC |
5.8 | -7.0 | -10.3 |
| #4: BIOCHEM PHARMA INC |
4.1 | 16.0 | 14.9 |
| Total of #1-4: | 74.1 | -6.5 | 1.3 |